SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Naredi Peter) srt2:(2005-2009)"

Sökning: WFRF:(Naredi Peter) > (2005-2009)

  • Resultat 1-10 av 29
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Hansson, Johan, 1964- (författare)
  • Loco-regional Treatment of Peritoneal Carcinomatosis: Survival, Morbidity and Quality of Life
  • 2009
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Peritoneal carcinomatosis (PC) is traditionally regarded as a terminal stage of disease with a poor prognosis and systemic chemotherapy is regarded as palliative treatment. In order to improve survival and even to achieve cure for selected patients with PC, cytoreductive surgery and intraperitoneal che-motherapy have been advocated. Despite complete macroscopic removal of tumour, residual microscopic malignant cells might result in recurrence. Intraperitoneal chemotherapy aims to kill residual malignant cells and thereby needs to be distributed in the entire peritoneal cavity. This aggres-sive combined loco-regional treatment has a high risk of morbidity and mor-tality. Whether the increased risks are acceptable to improve survival re-quires investigation and the impact of loco-regional treatment of PC on health-related quality of life (HRQL) needs to bee explored The overall aim of this thesis was to analyse the impact of cytoreductive surgery and intraperitoneal chemotherapy on patients with peritoneal carci-nomatosis. A significant survival improvement (median 32 months) was seen in 18 patients with PC of colorectal origin subjected to loco-regional treatment, in comparison to matched controls treated with systemic chemotherapy (me-dian survival 14 months, Paper I). The results of single-photon emission computer-tomography (SPECT) in 51 patients were correlated to the number of intraperitoneal chemotherapy courses that could be performed without further surgery (Paper II). Postoperative 30-days morbidity and 90-days mortality was investigated in 123 PC-patients after loco-regional treatment. Severe adverse events occurred in 51 (41%) patients. Five patients (4%) had treatment-related mortality. Stoma formation, duration of surgery, periopera-tive blood loss, and extent of PC was associated with morbidity (Paper III). HRQL was investigated in 64 patients. HRQL was negatively affected at 3 months but a partial recovery was seen at 8 months. 30-day morbidity did not have any impact on HRQL at 8 months (Paper IV). This treatment there fore appears justified despite considerable toxicity in view of possible life prolongation.
  •  
2.
  •  
3.
  • Björn, Erik, et al. (författare)
  • Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry
  • 2007
  • Ingår i: Analytical Biochemistry. - : Elsevier BV. - 0003-2697. ; 363, s. 135-42
  • Tidskriftsartikel (refereegranskat)abstract
    • A fast and robust method for the determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry was developed, characterized, and validated. Samples of isolated DNA and exosome fractions from human ovarian (2008) and melanoma (T289) cancer cell lines were used. To keep the sample consumption to approximately 10 μl and obtain a high robustness of the system, a flow injection sample introduction system with a 4.6-μl sample loop was used in combination with a conventional pneumatic nebulizer and a spray chamber. The system was optimized with respect to signal/noise ratio using a multivariate experimental design. The system proved to be well suited for routine analysis of large sample series, and several hundreds of samples could be analyzed without maintenance or downtime. The detection limit of the method was 0.12 pg (26 pg/g) platinum. To avoid systematic errors from nonspectral interferences, it was necessary to use reagent matched calibration standards or isotope dilution analysis. An uncertainty budget was constructed to estimate the total expanded uncertainty of the method, giving a quantification limit of 2.3 pg (0.5 ng/g) platinum in DNA samples. The uncertainty was sufficiently low to study quantitative differences in the formation of Pt–DNA adducts after treatment with cisplatin using different exposure times and concentrations.
  •  
4.
  • Bodén, Ida, 1977-, et al. (författare)
  • Characterization of healthy skin using near infrared spectroscopy and skin impedance
  • 2008
  • Ingår i: Medical and Biological Engineering and Computing. - : Springer Science and Business Media LLC. - 0140-0118 .- 1741-0444. ; 46:10, s. 985-995
  • Tidskriftsartikel (refereegranskat)abstract
    • Near infrared spectroscopy (NIR) and skin impedance (IMP) spectroscopy are two methods suggested for diagnoses of diseases inducing adverse effects in skin. The reproducibility of these methods and their potential value in non-invasive diagnostics were investigated. Measurements were performed in vivo on healthy skin at five anatomic body sites on eight young women. partial least squares discriminant analysis showed that both methods were useful for classification of the skin characteristics at the sites. Inter-individually the NIR model gave 100% correct classification while the IMP model provided 92%. Intra-individually the NIR model gave 88% correct classification whereas the IMP model did not provide any useful classification. The correct classification was increased to 93% when both datasets were combined, which demonstrates the value of adding information. Partial least squares discriminant analysis gave 72% correct predictions of skin sites while the combined model slightly improved to 73%.
  •  
5.
  • Brorson, Håkan, et al. (författare)
  • Lymfsystemet och dess sjukdomar.
  • 2005
  • Ingår i: Kirurgi. - 9789144043555 ; 2nd ed, s. 469-488
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Hammarström, Anne, et al. (författare)
  • Dags att bryta den mansdominerade katedrala undervisningen
  • 2007
  • Ingår i: Socialmedicinsk Tidskrift. - Stockholm : Socialmedicinsk tidskrift. - 0037-833X. ; 84:6, s. 560-562
  • Tidskriftsartikel (refereegranskat)abstract
    • Students at the medical programme at Umeå university point out the lack of female lecturers. The aim of this study was to see how many men respectively women our students meet as teachers in different teaching situations and to analyze the result from a student perspective. Students more often meet men than women in cathedral lectures. The male dominance is less obvious in group teaching and supervision. The medical programme should pay effort to have more women as cathedral lecturers.
  •  
10.
  • Hemmingsson, Oskar, 1975-, et al. (författare)
  • ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite
  • 2009
  • Ingår i: Cancer Chemotherapy and Pharmacology. - : Springer. - 0344-5704 .- 1432-0843. ; 63:3, s. 491-499
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose ASNA1 is homologous to E. coli ArsA, a well characterized ATPase involved in efflux of arsenite and antimonite. Cells resistant to arsenite and antimonite are cross-resistant to the chemotherapeutic drug cisplatin. ASNA1 is also an essential ATPase for the insertion of tail-anchored proteins into ER membranes and a novel regulator of insulin secretion. The aim of this study was to determine if altered ASNA1 levels influenced growth and sensitivity to arsenite and cisplatin in human melanoma cells.Methods Cultured melanoma T289 cells were transfected with plasmids containing sense or antisense ASNA1. Cells were exposed to cisplatin, arsenite and zinc. Cell growth and chemosensitivity were evaluated by the MTT assay and apoptosis by a TUNEL assay.Results ASNA1 expression was necessary for growth. T289 clones with decreased ASNA1 expression exhibited 51 ± 5% longer doubling times than wildtype T289 (P = 0.0091). After exposure to cisplatin, ASNA1 downregulated cells displayed a significant increase in apoptosis. The cisplatin IC50 in ASNA1 underexpressing cells was 41.7 ± 1.8% compared to wildtype (P = 0.00097) and the arsenite IC50 was 59.9 ± 3.2% of wildtype IC50 (P = 0.0067).Conclusions Reduced ASNA1 expression is associated with significant inhibition of cell growth, increased apoptosis and increased sensitivity to cisplatin and arsenite.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 29
Typ av publikation
tidskriftsartikel (23)
doktorsavhandling (3)
bokkapitel (2)
bok (1)
Typ av innehåll
refereegranskat (22)
övrigt vetenskapligt/konstnärligt (7)
Författare/redaktör
Naredi, Peter (13)
Naredi, Peter, 1955 (9)
Audisio, Riccardo A (3)
Naredi, Peter, Profe ... (3)
Rydén, Lisa (2)
Jeppsson, Bengt (2)
visa fler...
Friberg, Peter, 1956 (2)
Lambert, G (2)
Hemmingsson, Oskar, ... (2)
Öhlund, Daniel, 1979 ... (2)
Haglund, Ulf (2)
Sund, Malin, 1972- (1)
Andersson, Roland (1)
Abdiu, Avni (1)
Nilsson, David (1)
Björn, Erik (1)
Sund, Malin (1)
Hellstrand, Kristoff ... (1)
Gehlsen, Kurt (1)
Lindholm-Sethson, Br ... (1)
Hansson, Johan, 1964 ... (1)
Hammarström, Anne (1)
Gustavsson, Bengt, 1 ... (1)
Jeppsson, B (1)
Bergkvist, Leif (1)
Tylman-Mikiewicz, Ma ... (1)
Bengtsson, Anders, 1 ... (1)
Andersson, Ronny (1)
Hans-Inge, Peterson (1)
Bo, Risberg (1)
Peter, Naredi (1)
Romner, B (1)
Mahteme, Haile, Doce ... (1)
Ivarsson, Marie-Loui ... (1)
Ingvar, Christian (1)
Tuck, Simon (1)
Hafström, Lars-Olof, ... (1)
Rydenhag, Bertil, 19 ... (1)
Lundqvist, S (1)
Wallon, Conny, 1966- (1)
Brorson, Håkan (1)
Grände, Per-Olof (1)
Hocevar, Marko (1)
Mattsson, Jan (1)
Reinstrup, Peter (1)
Kao, Gautam, 1962- (1)
Kao, Gautam (1)
Naredi, Silvana, 195 ... (1)
Nygren, Yvonne (1)
Nhu Nguyen, Tam Trin ... (1)
visa färre...
Lärosäte
Umeå universitet (20)
Göteborgs universitet (7)
Uppsala universitet (4)
Lunds universitet (4)
Linköpings universitet (3)
Språk
Engelska (24)
Svenska (5)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (14)
Naturvetenskap (1)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy